EAACI International Severe Asthma Forum (ISAF) Hybrid 2023: Advancing Severe Asthma Care

Through cutting-edge research, interactive sessions, and meaningful collaborations, ISAF 2023 aspires to advance the severe asthma field and enhance the well-being of those affected by this condition. Through cutting-edge research, interactive sessions, and meaningful collaborations, ISAF 2023 aspires to advance the severe asthma field and enhance the well-being of those affected by this condition. The Organising Committee of ISAF Hybrid 2023 is excited to welcome participants to this...

Through cutting-edge research, interactive sessions, and meaningful collaborations, ISAF 2023 aspires to advance the severe asthma field and enhance the well-being of those affected by this condition.

The Organising Committee of ISAF Hybrid 2023 is excited to welcome participants to this exceptional scientific event and looks forward to productive discussions and collaborations that will shape the future of severe asthma management. Whether attending in person or virtually, ISAF 2023 promises to be an enriching and engaging experience for all.

Visit https://eaaci.org/events_meetings/isaf-2023/ for registration and program details.

About EAACI

The European Academy of Allergy and Clinical Immunology (EAACI) is the leading professional organization in the field of allergy and clinical immunology. EAACI strives to promote excellence in clinical care, research, education, and training in the field of allergy and clinical immunology. For more information about EAACI, please visit https://eaaci.org/ 

For more information, please contact our Marketing and Communications team at communications@eaaci.org

Contact for Media: Yaozi Moreno; +41 44 285 90 49

Photo - https://mma.prnewswire.com/media/2236467/ISAF_Hybrid.jpg
Logo - https://mma.prnewswire.com/media/2236465/EAACI_Logo.jpg
Logo - https://mma.prnewswire.com/media/2236466/ISAF_Logo.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/eaaci-international-severe-asthma-forum-isaf-hybrid-2023-advancing-severe-asthma-care-301944676.html